Positron Corporation Enters Agreement to Acquire FDA 510(k) for NeuSight PET-CT
Imaging Technology
JUNE 13, 2024
Our PET imaging product line will now feature PET-CT which will expand access for physicians and practitioners seeking to utilize the full capabilities of the PET modality in nuclear cardiology and oncology.
Let's personalize your content